146 related articles for article (PubMed ID: 6202319)
1. Interaction of human plasma kallikrein and its light chain with alpha 2-macroglobulin.
van der Graaf F; Rietveld A; Keus FJ; Bouma BN
Biochemistry; 1984 Apr; 23(8):1760-6. PubMed ID: 6202319
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of kallikrein in human plasma.
van der Graaf F; Koedam JA; Bouma BN
J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
[TBL] [Abstract][Full Text] [Related]
3. Interaction of human plasma kallikrein and its light chain with C1 inhibitor.
van der Graaf F; Koedam JA; Griffin JH; Bouma BN
Biochemistry; 1983 Sep; 22(20):4860-6. PubMed ID: 6556071
[TBL] [Abstract][Full Text] [Related]
4. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.
Schapira M; Scott CF; Colman RW
Biochemistry; 1981 May; 20(10):2738-43. PubMed ID: 6910423
[TBL] [Abstract][Full Text] [Related]
5. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
Olson ST; Sheffer R; Francis AM
Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human blood coagulation factor Xa by alpha 2-macroglobulin.
Meijers JC; Tijburg PN; Bouma BN
Biochemistry; 1987 Sep; 26(18):5932-7. PubMed ID: 2445377
[TBL] [Abstract][Full Text] [Related]
7. Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions.
Olson ST; Francis AM; Sheffer R; Choay J
Biochemistry; 1993 Nov; 32(45):12148-59. PubMed ID: 8218292
[TBL] [Abstract][Full Text] [Related]
8. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains.
Bock PE; Shore JD; Tans G; Griffin JH
J Biol Chem; 1985 Oct; 260(23):12434-43. PubMed ID: 3850090
[TBL] [Abstract][Full Text] [Related]
9. Isolation and functional properties of the heavy and light chains of human plasma kallikrein.
van der Graaf F; Tans G; Bouma BN; Griffin JH
J Biol Chem; 1982 Dec; 257(23):14300-5. PubMed ID: 6815193
[TBL] [Abstract][Full Text] [Related]
10. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma.
Schapira M; Scott CF; Colman RW
J Clin Invest; 1982 Feb; 69(2):462-8. PubMed ID: 6173399
[TBL] [Abstract][Full Text] [Related]
11. Study of the effect of high molecular weight kininogen upon the fluid-phase inactivation of kallikrein by C1 inhibitor.
Silverberg M; Longo J; Kaplan AP
J Biol Chem; 1986 Nov; 261(32):14965-8. PubMed ID: 3639874
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein.
Kerbiriou DM; Bouma BN; Griffin JH
J Biol Chem; 1980 May; 255(9):3952-8. PubMed ID: 6154706
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional characterization of the inhibition of urokinase by alpha 2-macroglobulin.
Straight DL; Hassett MA; McKee PA
Biochemistry; 1985 Jul; 24(15):3902-7. PubMed ID: 2413880
[TBL] [Abstract][Full Text] [Related]
14. Hydrolysis of plasma kallikrein by trypsin and plasmin and the formation of active fragments.
Sampaio CA; Vidmar S; Hamaguchi A; Sampaio MU
Adv Exp Med Biol; 1986; 198 Pt B():105-11. PubMed ID: 2949543
[TBL] [Abstract][Full Text] [Related]
15. Generation of an esterolytic and kinin-forming kallikrein-alpha2-macroglobulin complex in human serum by treatment with acetone.
Vogt V; Dugal B
Naunyn Schmiedebergs Arch Pharmacol; 1976 Jul; 294(1):75-84. PubMed ID: 63921
[TBL] [Abstract][Full Text] [Related]
16. Human plasma kallikrein. Immunoreactivity and activity on natural and synthetic substrates.
Motta G; Sampaio CA; Sampaio MU
Agents Actions Suppl; 1992; 36():200-8. PubMed ID: 1609643
[TBL] [Abstract][Full Text] [Related]
17. Effect of cleavage of the heavy chain of human plasma kallikrein on its functional properties.
Colman RW; Wachtfogel YT; Kucich U; Weinbaum G; Hahn S; Pixley RA; Scott CF; de Agostini A; Burger D; Schapira M
Blood; 1985 Feb; 65(2):311-8. PubMed ID: 3871342
[TBL] [Abstract][Full Text] [Related]
18. Plasma arginine esterase in cystic fibrosis: kinetics of activation, identification as plasma kallikrein, reaction with alpha 2-macroglobulin and comparison with levels in normal plasma.
Bury AF; Barrett AJ
Pediatr Res; 1982 Aug; 16(8):613-20. PubMed ID: 6180371
[TBL] [Abstract][Full Text] [Related]
19. Identification of alpha 2-macroglobulin as a cytokine binding plasma protein. Binding of interleukin-1 beta to "F" alpha 2-macroglobulin.
Borth W; Luger TA
J Biol Chem; 1989 Apr; 264(10):5818-25. PubMed ID: 2466831
[TBL] [Abstract][Full Text] [Related]
20. Reaction of nerve growth factor gamma and 7S nerve growth factor complex with human and murine alpha 2-macroglobulin.
Wolf BB; Vasudevan J; Gonias SL
Biochemistry; 1993 Feb; 32(7):1875-82. PubMed ID: 7679924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
